One-line thesis: Wise is building the global infrastructure monopoly for cross-border money movement using the Scale Economies Shared playbook — deliberately cutting take-rates to widen the cost moat, growing 18–24% on underlying income at 0.57% market share of a £32 trillion TAM. The business is exceptional; the price is full.
WISE-DOSSIER.md §1 [1]| Line | FY2025 | FY2026 | YoY |
|---|---|---|---|
| Active customers | 15.6m | 18.9m | +21% |
| Cross-border volume | £145bn | £181.7bn | +25% |
| Customer holdings | ~£21.5bn | £29.4bn | +37% |
| Underlying income | £1,362m | £1,609m | +18% (+19% cc) |
| Cross-border take-rate (avg) | ~56bps | ~52bps | -4bps (by design) |
| Instant transfers (Q4) | 65% | 75% | +10pp |
| Implied Underlying PBT | ~£300m | ~£257m | -14% (deliberate) |
| Q4 FY26 detail | Q4 FY25 | Q4 FY26 | YoY |
|---|---|---|---|
| Active customers | 9.29m | 11.29m | +22% |
| Cross-border volume | £39.1bn | £49.4bn | +26% (+27% cc) |
| Underlying income | £350.4m | £435.3m | +24% |
| Card and other revenue | £100.9m | £130.2m | +29% |
| Cross-border take-rate | 0.53% | 0.51% | -2bps |
WISE-DOSSIER.md §2 & §5 · WiseplcQ4FY26TradingUpdate(2).pdf [1] [3]WISE-DOSSIER.md §5 & §7 [1]WISE-DOSSIER.md §1 & §5 [1]WISE-DOSSIER.md §3 [1]| Moat type | Strength | Evidence |
|---|---|---|
| Low-cost producer (SES) | Strong | 67bps→51bps take-rate over 2yrs is a deliberate price weapon. Each cut compounds the cost gap vs banks and challengers. |
| Intangible assets (licenses) | Strong | 70+ regulatory licenses across 160+ countries; multi-year regulatory investment that cannot be replicated quickly. |
| Scale / infrastructure | Strong | 8 direct payment-system connections; first non-bank in UK Faster Payments, Japan Zengin. Australia direct lifted instant from 24% to 83%. |
| Switching costs | Medium | Multi-currency holdings, local account details (UK sort code, EU IBAN, US routing) and recurring use of card / interest. Holdings £29.4bn signals deep stickiness. |
| Network effects | Medium | 70% word-of-mouth acquisition is a real demand-side network. Platform is a B2B network growing 3× group average. |
| Regulatory complexity | Medium | 160+ country compliance burden is its own moat against AI-native challengers and new entrants. |
WISE-DOSSIER.md §1 & §5 · WiseH1FY26AnalystPresentation.pdf [1] [4]Selected from the 26-item framework. Items shown are the strongest supporting points and the most material concerns for Wise specifically.
WISE-DOSSIER.md §5 & §6 · Meta analysis from poorcharlie.io.txt (framework) [1] [8]WISE-DOSSIER.md §3 · WiseFY2025AnnualReportAccounts.pdf pp.103–117 · Wise plc (WIZEY) Q2 2026 Earnings C.md [1] [5] [6]No major M&A history — Wise has grown organically. Capital return is via buybacks (anti-dilution) plus reinvestment in pricing, hiring, marketing, and the dual listing.
| Action | Year | Strategic role | Outcome |
|---|---|---|---|
| Direct LSE listing (no IPO) | 2021 | Public market access; avoid banker spread | Successful direct listing |
| Take-rate reset to 13–16% margin target | FY25 | SES playbook — price cuts to widen moat | Volume +25% offset rate cut; income +18% |
| 25m share buyback program | FY26 | Offset employee option dilution | ~50% complete by H1 close |
| Marketing spend +59% H1 FY26 | FY26 | Brand reinvestment (Canada, NZ, US, UK) | Customer adds +14%; payback held at 6 months |
| Nasdaq dual listing | 2026 | US institutional access; Platform credibility | Approved Jul 2025; expected May 11, 2026 (slight delay) |
| No dividends | ongoing | Reinvest at high ROIC | Correct math for growth-stage compounder |
WISE-DOSSIER.md §3 & §5 [1]| Promise | When | Outcome | Consistent? |
|---|---|---|---|
| Reinvest FY25 margin surplus from 22% back to 13–16% | Owners Day Apr 25 | FY26 guided ~16% (top of range); H1 FY26 came in at 16.3% | Yes |
| Take-rate cuts will drive volume that offsets revenue impact | H1 FY25 | Volume +25% FY26 on take-rate down ~4bps; income still +18% | Yes |
| Underlying income to grow 15–20% cc mid-term | Ongoing | FY26 +19% cc; Q4 FY26 +24% — accelerating into range | Yes / beating |
| Platform 10% volume medium-term, 50% long-term | Owners Day 2025 | 3% → 4% → 5% over three consecutive reporting periods | On track |
| Complete Nasdaq dual listing around Q2 FY27 | Jun 2025 | Guided May 11, 2026 — slipped from original Q4 FY26 guide | Slight delay |
| MMET examination resolved; remediation on track | H1 FY26 | $4.2m consent order paid; no further escalation | Yes |
| Marketing payback 6 months despite +59% spend | H1 FY26 | Customer adds +14% H1 FY26 vs prior year; Australia CPA trending down | Yes |
| No material price adjustments in H2 FY26 — reset done | H1 FY26 | Q3/Q4 take-rate held at 52bps then ticked down 1bp to 51bps | Yes |
WISE-DOSSIER.md §4 · WISEplcH1FY26Results.pdf [1] [4]| Metric | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|
| FCF Growth (Per Share) % | 56.80% | 11.30% | 24.70% | 0% |
| Revenue Growth (Per Share) % | 12.50% | 45.80% | 44.20% | 0% |
| EPS without NRI Growth % | -5.50% | 131.90% | 102.20% | 0% |
Portfolio snapshot 30.05.2026.txt (GuruFocus export) [9]| Metric | Current | 5Y Growth Rate | 5Y Median |
|---|---|---|---|
| Gross Margin % | 72.85% | 3.40% | N/A |
| Operating Margin % | 27.47% | 39.10% | 15.65% |
| FCF Margin % | 283.23% | N/A | 396.54% |
Portfolio snapshot 30.05.2026.txt [9]| Metric | Current | 5Y Median |
|---|---|---|
| ROIC % | 98.82% | 33.80% |
| ROCE % | 34.79% | 26.52% |
| ROE % | 29.02% | 22.33% |
| Cash Conversion Ratio | 13.72 | 34.31 |
| Period | ROIIC % |
|---|---|
| 1-Year | -24.69% |
| 3-Year | 201.09% |
| 5-Year | 129.10% |
Portfolio snapshot 30.05.2026.txt [9]| Metric | Current |
|---|---|
| Debt-to-Equity | 0.21 |
| Cash-to-Debt | 49.38 |
| Interest Coverage | 30.38 |
| Current Ratio | 1.08 |
Portfolio snapshot 30.05.2026.txt [9]| Metric | Current |
|---|---|
| 1-Year Dividend Growth Rate (Per Share) % | N/A |
| 3-Year Dividend Growth Rate (Per Share) % | N/A |
| Dividends per Share (TTM) | £0 |
| 1-Year Share Buyback Ratio | N/A |
| 3-Year Share Buyback Ratio | 0.50 |
| 5-Year Share Buyback Ratio | -0.50 |
| Goodwill-to-Asset % | 0 |
| Stock Based Compensation (mm) | £57.20M |
| Free Cash Flow (mm) | £5,293.50M |
Portfolio snapshot 30.05.2026.txt [9]| Multiple | Current | 10yr median | Read |
|---|---|---|---|
| P / FCF | 1.9x | 2.3x | Customer balances inflate reported FCF |
| EV / FCF | -1.0x | — | Customer balances net against EV |
| EV / EBIT | -9.5x | — | Negative on customer-balance treatment |
| P / E (no NRI) | 25.5x | — | Cleaner lens; still cheaper than Underlying PBT view |
| FCF Yield | 54.86% | — | Inflated by customer deposit inflows |
WISE-DOSSIER.md §8 [1]Two-stage model on Underlying PBT, 10% discount rate, 20-year horizon. Underlying PBT/share ~£0.20 (£257m / ~1.3bn diluted shares). Current price ~£9.02.
| Stage | Growth assumption | Terminal | Implied value |
|---|---|---|---|
| Growth stage (yrs 1–10) | ~25% | — | — |
| Terminal stage (yrs 11+) | — | 3% | — |
| Market-implied price | — | — | ~£9.00 |
WISE-DOSSIER.md §8 [1]| Scenario | Growth yrs 1–10 | Terminal | Fair value | vs £9.02 |
|---|---|---|---|---|
| Market implied | 25% | 3% | ~£9.00 | — |
| Bear (deceleration) | 15% | 3% | ~£5.50 | -39% |
| Base | 20% | 3% | ~£7.20 | -20% |
| Bull | 30% | 3% | ~£11.80 | +31% |
WISE-DOSSIER.md §8 [1]WISE-DOSSIER.md §6 [1]Company information/Wise/WISE-DOSSIER.mdLiving research-report source file, last updated 2026-05-25. Primary reference for all qualitative and quantitative content unless otherwise noted.Company information/Wise/WISE-earnings-analysis-FY2026.mdInternal earnings analysis covering FY2026 trading updates and H1 results.Company information/Wise/images_0b17713eb11c498dc0c048170c794501-WiseplcQ4FY26TradingUpdate(2).pdfQ4 FY26 Trading Update, dated 13 April 2026 — primary source for Q4 and full-year FY26 figures.Company information/Wise/images_04bfdcbc39ddf7b9cbd06aea398e014b-WISEplcH1FY26Results.pdf and WiseH1FY26AnalystPresentation.pdfH1 FY26 results (6 November 2025) and analyst presentation — primary source for take-rate, margin, and Platform commentary.Company information/Wise/images_ad736416f90791dbb49c7e59f1f45d8d-WiseFY2025AnnualReportAccounts.pdfFY2025 annual report and accounts — primary source for FY2025 figures and historical context.Company information/Wise/Wise plc (WIZEY) Q2 2026 Earnings C.md and Wise plc (WPLCF) Q4 2025 Earnings C.mdEarnings call transcripts — primary source for Käärmann and Thomassin commentary on pricing, Platform, and dual listing.Company information/Wise/Wise plc (WPLCF) Half Year Results fy2025.mdHalf-year results call transcript referenced for the FY25 margin surplus reinvestment commitment.Stock portfolio/Meta analysis from poorcharlie.io.txtScoring framework and 26-item additional-moat checklist; used for the structure of Part 2.4 only, not for Wise-specific content.Portfolio snapshot 30.05.2026.txtGuruFocus portfolio snapshot exported 2026-05-30; primary source for Part 4 ratios.This is one of three free sample reports.
Members get the full research universe: all 47 today, growing to 80, with quarterly updates after every earnings release.